Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

• Main Authors: Hiroshi Nomoto (Author), Yuka Takahashi (Author), Yoshinari Takano (Author), Hiroki Yokoyama (Author), Kazuhisa Tsuchida (Author), So Nagai (Author), Aika Miya (Author), Hiraku Kameda (Author), Kyu Yong Cho (Author), Akinobu Nakamura (Author), Tatsuya Atsumi (Author)
• Format: Book
• Published: MDPI AG, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is an important common comorbidity in individuals with type 2 diabetes (T2DM). Although some glucagon-like peptide-1 receptor agonists (GLP-1RAs) have beneficial effects on NAFLD, the efficacy of once-weekly semaglutide has not been established. This was a s...